Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sulgey G"'
Autor:
Garzan A; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Ahmed SK; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Haese NN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Sulgey G; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Medica S; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Smith JL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Zhang S; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Ahmad F; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Karyakarte S; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Rasmussen L; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., DeFilippis V; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Tekwani B; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Bostwick R; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Suto MJ; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Hirsch AJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Morrison TE; Department of Immunology and Microbiology, University of Colorado School of Medicine, 12800 E. 19th Avenue, Aurora, Colorado 80045, United States., Heise MT; Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States., Augelli-Szafran CE; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Pathak AK; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States., Moukha-Chafiq O; Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Dec 12; Vol. 67 (23), pp. 20858-20878. Date of Electronic Publication: 2024 Dec 02.
Autor:
Medica S; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA., Denton M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Diggins NL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Kramer-Hansen O; Department of Biomedical Sciences Molecular Pharmacology, University of Copenhagen, Copenhagen, Denmark., Crawford LB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Mayo AT; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Perez WD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Daily MA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Parkins CJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Slind LE; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Pung LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Weber WC; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA., Jaeger HK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Streblow ZJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Sulgey G; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Kreklywich CN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Alexander T; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Rosenkilde MM; Department of Biomedical Sciences Molecular Pharmacology, University of Copenhagen, Copenhagen, Denmark., Caposio P; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Hancock MH; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, USA.
Publikováno v:
Journal of virology [J Virol] 2024 Dec 10, pp. e0180124. Date of Electronic Publication: 2024 Dec 10.
Autor:
Weber WC; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA., Andoh TF; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Kreklywich CN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Streblow ZJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Denton M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Streblow MM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Powers JM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Sulgey G; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Medica S; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Dmitriev I; Cancer Biology Division, Department of Radiation Oncology, Washington University, St. Louis, MO 63110, USA., Curiel DT; Cancer Biology Division, Department of Radiation Oncology, Washington University, St. Louis, MO 63110, USA., Haese NN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR 97006, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Aug 27; Vol. 12 (9). Date of Electronic Publication: 2024 Aug 27.
Autor:
Weber WC; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA., Streblow ZJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Kreklywich CN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Denton M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Sulgey G; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Streblow MM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA., Marcano D; Ponce Research Institute, Ponce Health Sciences University, Ponce 00716, Puerto Rico., Flores PN; Ponce Research Institute, Ponce Health Sciences University, Ponce 00716, Puerto Rico., Rodriguez-Santiago RM; Ponce Research Institute, Ponce Health Sciences University, Ponce 00716, Puerto Rico., Alvarado LI; Ponce Research Institute, Ponce Health Sciences University, Ponce 00716, Puerto Rico., Rivera-Amill V; Ponce Research Institute, Ponce Health Sciences University, Ponce 00716, Puerto Rico., Messer WB; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA., Hochreiter R; Valneva Austria GmbH, 1030 Vienna, Austria., Kosulin K; Valneva Austria GmbH, 1030 Vienna, Austria., Dubischar K; Valneva Austria GmbH, 1030 Vienna, Austria., Buerger V; Valneva Austria GmbH, 1030 Vienna, Austria., Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR 97006, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Aug 07; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 07.